Cambridge Research Biochemicals (CRB) has announced that it has extended its contract with RCUK Shared Services Centre Ltd (RCUK SSC Ltd) to supply custom synthesized peptides and custom generated polyclonal and monoclonal antibodies for a further 12 months.
CRB Commercial Director, Emily Humphrys commented, “We are delighted with the extension of this contract which demonstrates our strong performance over the last two years in providing high quality research peptide and antibody tools. As a company we are recognized for constantly reaching the high technical and service standards required by the Research Councils. This agreement is an acknowledgement of the value of our focus on quality and innovation in the production of speciality research peptides and antibodies.”
Mike Reilly, Category Manager for RCUK SSC Ltd commented “throughout the two year period we have been working with CRB, they have always demonstrated a very high level of professionalism and commitment to the quality and ethical standards of the products they supply to us. We are delighted to extend their contract as a supply partner and look forward to continuing our mutually beneficial relationship."
CRB is the world’s second oldest peptide manufacturer. The company has long-standing relationships with some of the largest international pharmaceutical and biotechnology companies and research institutions.
CRB custom services include:
• Peptide Synthesis
• Polyclonal Antibody Production
• Monoclonal Antibody Production
• Fluorescent Dye Labelling